<p class&equals;"p1">COVID-19 has succeeded in bringing much of the world to a screeching halt&period; There have been over 44 million reported cases&comma; with over 1&period;6 million deaths worldwide&period; It has also decimated economies as a result of the shutdowns and restrictions on certain activities&period;<&sol;p>&NewLine;<&excl;-- WP QUADS Content Ad Plugin v&period; 2&period;0&period;99 -->&NewLine;<div class&equals;"quads-location quads-ad135805 " id&equals;"quads-ad135805" style&equals;"float&colon;none&semi;text-align&colon;center&semi;padding&colon;0px 0 0px 0&semi;" data-lazydelay&equals;"3000">&NewLine;&NewLine;<&sol;div>&NewLine;&NewLine;<p class&equals;"p1">The world’s leading drug manufacturers and researchers are attempting to create a vaccine that will allow us to return to normal&period; Unlike the development of most vaccines&comma; world leaders have pressed to get a vaccine fast&period;<&sol;p>&NewLine;<p class&equals;"p1">There are several COVID-19 vaccine trials in various phases going on right now&period; What types of vaccine categories are being tested and how would they work&quest;<&sol;p>&NewLine;<p class&equals;"p1">We go over some of the most promising candidates&period;<&sol;p>&NewLine;<&excl;-- WP QUADS Content Ad Plugin v&period; 2&period;0&period;99 -->&NewLine;<div class&equals;"quads-location quads-ad135804 " id&equals;"quads-ad135804" style&equals;"float&colon;none&semi;text-align&colon;center&semi;padding&colon;0px 0 0px 0&semi;" data-lazydelay&equals;"3000">&NewLine;&NewLine;<&sol;div>&NewLine;&NewLine;<p class&equals;"p2"><b>A Look at the Types of Vaccine Categories<&sol;b><&sol;p>&NewLine;<p class&equals;"p1">There are several COVID-19 vaccine categories&period; Each type works in different ways&period; In some cases&comma; different drugs are being combined to create a new vaccine&period; Here are the basic types of vaccines and how they work&period;<&sol;p>&NewLine;<p class&equals;"p3"><b>Inactivated Vaccine<&sol;b><&sol;p>&NewLine;<p class&equals;"p1">This treatment starts by killing a whole virus&period; The inactivated version is then used to create a vaccine&period; This allows your body’s immune system to recognize and kill the virus when it sees it&period; There are many medicines that use this approach&comma; including the polio vaccine&period;<&sol;p>&NewLine;<&excl;-- WP QUADS Content Ad Plugin v&period; 2&period;0&period;99 -->&NewLine;<div class&equals;"quads-location quads-ad135804 " id&equals;"quads-ad135804" style&equals;"float&colon;none&semi;text-align&colon;center&semi;padding&colon;0px 0 0px 0&semi;" data-lazydelay&equals;"3000">&NewLine;&NewLine;<&sol;div>&NewLine;&NewLine;<p class&equals;"p3"><b>Sub-unit Vaccine<&sol;b><&sol;p>&NewLine;<p class&equals;"p1">This method uses a piece of the virus&comma; such as a protein&comma; to create a vaccine&period; Hepatitis and human papillomavirus &lpar;HPV&rpar; vaccines use this approach&period;<&sol;p>&NewLine;<p class&equals;"p3"><b>Weakened&comma; Live Viral Vaccine<&sol;b><&sol;p>&NewLine;<p class&equals;"p1">Here the virus is grown in a lab&period; The virus eventually becomes better at growing in the lab&comma; making it less capable of reproducing in people&period; The measles&comma; mumps&comma; rubella&comma; and chickenpox vaccines all use this method&period;<&sol;p>&NewLine;<&excl;-- WP QUADS Content Ad Plugin v&period; 2&period;0&period;99 -->&NewLine;<div class&equals;"quads-location quads-ad135804 " id&equals;"quads-ad135804" style&equals;"float&colon;none&semi;text-align&colon;center&semi;padding&colon;0px 0 0px 0&semi;" data-lazydelay&equals;"3000">&NewLine;&NewLine;<&sol;div>&NewLine;&NewLine;<p class&equals;"p3"><b>Replicating Viral Vector Vaccine<&sol;b><&sol;p>&NewLine;<p class&equals;"p1">This method uses a virus that doesn’t result in a disease in people &&num;8211&semi; it&&num;8217&semi;s called a virus vector&period; A new gene code is then created in the virus vector&period; Most of the potential COVID-19 vaccines use a coronavirus spike protein&period;<&sol;p>&NewLine;<p class&equals;"p1">The spike protein attaches to the virus vector and then it reproduces in the cells&period; This causes the immune system to create antibodies to the COVID-19 spike protein&period;<&sol;p>&NewLine;<p class&equals;"p1">Researchers created the Ebola vaccine using this method&period;<&sol;p>&NewLine;<&excl;-- WP QUADS Content Ad Plugin v&period; 2&period;0&period;99 -->&NewLine;<div class&equals;"quads-location quads-ad135804 " id&equals;"quads-ad135804" style&equals;"float&colon;none&semi;text-align&colon;center&semi;padding&colon;0px 0 0px 0&semi;" data-lazydelay&equals;"3000">&NewLine;&NewLine;<&sol;div>&NewLine;&NewLine;<p class&equals;"p2"><b>FDA Fast Track Testing<&sol;b><&sol;p>&NewLine;<p class&equals;"p1">The <a href&equals;"https&colon;&sol;&sol;www&period;fda&period;gov&sol;patients&sol;fast-track-breakthrough-therapy-accelerated-approval-priority-review&sol;fast-track"><span class&equals;"s1">FDA Fast Track process<&sol;span><&sol;a> works to help with the testing and review of possible vaccines and new drugs&period;<&sol;p>&NewLine;<p class&equals;"p1">A drug must meet certain qualifications to be fast-tracked&period; Above all&comma; it must be for a disease that has no current therapy&period; It must also show advantages over similar therapies or vaccines&period;<&sol;p>&NewLine;<p class&equals;"p1">Several potential COVID-19 vaccines have been &OpenCurlyDoubleQuote;fast-tracked”&period;<&sol;p>&NewLine;<&excl;-- WP QUADS Content Ad Plugin v&period; 2&period;0&period;99 -->&NewLine;<div class&equals;"quads-location quads-ad135804 " id&equals;"quads-ad135804" style&equals;"float&colon;none&semi;text-align&colon;center&semi;padding&colon;0px 0 0px 0&semi;" data-lazydelay&equals;"3000">&NewLine;&NewLine;<&sol;div>&NewLine;&NewLine;<p class&equals;"p2"><b>Promising Drugs Under Trial<&sol;b><&sol;p>&NewLine;<p class&equals;"p1">Let’s take a look at some of the drugs that are being developed&period; Many of these are in Phase 3 vaccine trials&period; Phase 3 means that thousands of people can take the drug in a controlled environment&period;<&sol;p>&NewLine;<p class&equals;"p1"><b>AZD1222<&sol;b> &lpar;AstraZeneca-Oxford&rpar;<&sol;p>&NewLine;<p class&equals;"p1">This is a replication-deficient viral vector vaccine&period; It uses an adenovirus from a chimpanzee&period; Preliminary testing has shown an &OpenCurlyDoubleQuote;acceptable safety profile”&comma; with all patients showing a positive response after two doses&period;<&sol;p>&NewLine;<&excl;-- WP QUADS Content Ad Plugin v&period; 2&period;0&period;99 -->&NewLine;<div class&equals;"quads-location quads-ad135804 " id&equals;"quads-ad135804" style&equals;"float&colon;none&semi;text-align&colon;center&semi;padding&colon;0px 0 0px 0&semi;" data-lazydelay&equals;"3000">&NewLine;&NewLine;<&sol;div>&NewLine;&NewLine;<p class&equals;"p1"><b>CoronaVac<&sol;b> &lpar;Sinovac&rpar;<&sol;p>&NewLine;<p class&equals;"p1">This drug is an inactivated vaccine&period; So far&comma; the various trials appear to show it is safe with older trial participants&period; No serious adverse effects have been reported&period;<&sol;p>&NewLine;<p class&equals;"p1"><b>JNJ-78436735<&sol;b> &lpar;Johnson &amp&semi; Johnson&rpar;<&sol;p>&NewLine;<p class&equals;"p1">This is a non-replicating viral vector vaccine&period; Johnson &amp&semi; Johnson plans to enroll up to 60&comma;000 people in a Phase 3 trial&period; According to releases&comma; a single injection seems to show &OpenCurlyDoubleQuote;robust neutralization antibody responses and provided complete…protection”&period;<&sol;p>&NewLine;<&excl;-- WP QUADS Content Ad Plugin v&period; 2&period;0&period;99 -->&NewLine;<div class&equals;"quads-location quads-ad135804 " id&equals;"quads-ad135804" style&equals;"float&colon;none&semi;text-align&colon;center&semi;padding&colon;0px 0 0px 0&semi;" data-lazydelay&equals;"3000">&NewLine;&NewLine;<&sol;div>&NewLine;&NewLine;<p class&equals;"p1"><b>mRNA-1273<&sol;b> &lpar;Moderna&rpar;<&sol;p>&NewLine;<p class&equals;"p1">This is an mRNA-based vaccine&period; It’s based on studies of similar coronaviruses like SARS and MERS&period;<&sol;p>&NewLine;<p class&equals;"p1">mRNA vaccines work by training the body to recognize the proteins attached to a virus&period; Unlike vaccines that use inactivated doses of the virus&comma; mRNA drugs trick your body into producing viral proteins on its own&period; This helps your immune system fight off infection&period;<&sol;p>&NewLine;<p class&equals;"p1">According to Moderna&comma; the vaccine showed &&num;8220&semi;neutralizing activity and limited inflammation&&num;8221&semi; in mice&period; It&&num;8217&semi;s been fast-tracked for Phase 3 trials&period; <a href&equals;"https&colon;&sol;&sol;www&period;sciencemag&period;org&sol;news&sol;2017&sol;02&sol;mysterious-2-billion-biotech-revealing-secrets-behind-its-new-drugs-and-vaccines"><span class&equals;"s1">Moderna Co-Founder Kenneth Chien<&sol;span><&sol;a> sees much hope for an effective COVID-19 vaccine in the near future&period;<&sol;p>&NewLine;<&excl;-- WP QUADS Content Ad Plugin v&period; 2&period;0&period;99 -->&NewLine;<div class&equals;"quads-location quads-ad135804 " id&equals;"quads-ad135804" style&equals;"float&colon;none&semi;text-align&colon;center&semi;padding&colon;0px 0 0px 0&semi;" data-lazydelay&equals;"3000">&NewLine;&NewLine;<&sol;div>&NewLine;&NewLine;<p class&equals;"p1"><b>NVX-CoV2373<&sol;b> &lpar;Novavax&rpar;<&sol;p>&NewLine;<p class&equals;"p1">This is a nanoparticle vaccine&period; Early phase trials showed that participants who received multiple doses had a favorable safety profile&period; The company plans to manufacture 1 billion doses by 2021&period;<&sol;p>&NewLine;<p class&equals;"p1">The drug is now in Phase 3 trials in the U&period;K&period; with 10&comma;000 participants involved in the study&period;<&sol;p>&NewLine;<p class&equals;"p1"><b>Bacillus Calmette-Guerin<&sol;b> &lpar;University of Melbourne &amp&semi; Murdoch Children’s Research Institute&rpar;<&sol;p>&NewLine;<&excl;-- WP QUADS Content Ad Plugin v&period; 2&period;0&period;99 -->&NewLine;<div class&equals;"quads-location quads-ad135804 " id&equals;"quads-ad135804" style&equals;"float&colon;none&semi;text-align&colon;center&semi;padding&colon;0px 0 0px 0&semi;" data-lazydelay&equals;"3000">&NewLine;&NewLine;<&sol;div>&NewLine;&NewLine;<p class&equals;"p1">This vaccine was originally created to prevent tuberculosis &lpar;TB&rpar; in people who have a higher risk&period; It works by boosting the immune system to fight infections&period;<&sol;p>&NewLine;<p class&equals;"p1">The Phase 3 trial is being conducted with over 4&comma;000 healthcare workers in hospitals in Australia&period; There is another Phase 3 trial in the Netherlands&comma; with around 1&comma;500 healthcare workers&period;<&sol;p>&NewLine;<p class&equals;"p1"><b>BNT162<&sol;b> &lpar;Pfizer&sol;BioNTech&rpar;<&sol;p>&NewLine;<p class&equals;"p1">This drug is another mRNA-based vaccine&period; Pfizer and BioNTech received FDA Fast Track designation for two vaccines&comma; BNT162b1 and BNT162b2&period; The latter will now advance to Phase 2 and 3 trials as it had a better immune response and better tolerability&period;<&sol;p>&NewLine;<&excl;-- WP QUADS Content Ad Plugin v&period; 2&period;0&period;99 -->&NewLine;<div class&equals;"quads-location quads-ad135804 " id&equals;"quads-ad135804" style&equals;"float&colon;none&semi;text-align&colon;center&semi;padding&colon;0px 0 0px 0&semi;" data-lazydelay&equals;"3000">&NewLine;&NewLine;<&sol;div>&NewLine;&NewLine;<p class&equals;"p1">The companies asked the FDA to allow an expanded protocol with 44&comma;000 participants in a Phase 3 trial&period; If effective&comma; that would mean the vaccine could be ready for use as soon as December&period;<&sol;p>&NewLine;<p class&equals;"p1"><b>Covaxin<&sol;b> &lpar;Bharat Biotech&rpar;<&sol;p>&NewLine;<p class&equals;"p1">This Indian biotechnology company is partnering with the National Institute of Virology to develop an inactivated vaccine&period; In Phase 1&comma; rhesus macaques took the vaccine&period; A study showed an &&num;8220&semi;increase in neutralizing antibodies and reduced viral replication&&num;8221&semi;&period;<&sol;p>&NewLine;<p class&equals;"p1">It was also tested on a small group of fifty people&period; The results were encouraging&period; Covaxin is entering Phase 2 trials now&period;<&sol;p>&NewLine;<&excl;-- WP QUADS Content Ad Plugin v&period; 2&period;0&period;99 -->&NewLine;<div class&equals;"quads-location quads-ad135804 " id&equals;"quads-ad135804" style&equals;"float&colon;none&semi;text-align&colon;center&semi;padding&colon;0px 0 0px 0&semi;" data-lazydelay&equals;"3000">&NewLine;&NewLine;<&sol;div>&NewLine;&NewLine;<p class&equals;"p2"><b>Finally&comma; Some Promising News About COVID-19<&sol;b><&sol;p>&NewLine;<p class&equals;"p1">There is a reason to hope that we will have effective and safe types of vaccines for COVID-19 soon&period; Some of the brightest minds are working hard to create possible candidates&period; With the Fast Track process&comma; we could have a drug quicker than you might have guessed&period;<&sol;p>&NewLine;<p class&equals;"p1">Looking for other &&num;8220&semi;hopeful&&num;8221&semi; news&quest; Be sure to check out our site for other positive stories about health&sol;medicine&comma; science&comma; technology&comma; and world news&period;<&sol;p>&NewLine;&NewLine;<div class&equals;"essb&lowbar;links essb&lowbar;counter&lowbar;modern&lowbar;right essb&lowbar;displayed&lowbar;bottom essb&lowbar;share essb&lowbar;template&lowbar;default4-retina essb&lowbar;2123751921 print-no" id&equals;"essb&lowbar;displayed&lowbar;bottom&lowbar;2123751921" data-essb-postid&equals;"138042" data-essb-position&equals;"bottom" data-essb-button-style&equals;"button" data-essb-template&equals;"default4-retina" data-essb-counter-pos&equals;"right" data-essb-url&equals;"https&colon;&sol;&sol;www&period;explosion&period;com&sol;138042&sol;a-look-at-possible-covid-19-vaccines-coming-soon&sol;" data-essb-fullurl&equals;"https&colon;&sol;&sol;www&period;explosion&period;com&sol;138042&sol;a-look-at-possible-covid-19-vaccines-coming-soon&sol;" data-essb-instance&equals;"2123751921"><ul class&equals;"essb&lowbar;links&lowbar;list"><li class&equals;"essb&lowbar;item essb&lowbar;link&lowbar;facebook nolightbox essb&lowbar;link&lowbar;svg&lowbar;icon"> <a href&equals;"https&colon;&sol;&sol;www&period;facebook&period;com&sol;sharer&sol;sharer&period;php&quest;u&equals;https&percnt;3A&percnt;2F&percnt;2Fwww&period;explosion&period;com&percnt;2F138042&percnt;2Fa-look-at-possible-covid-19-vaccines-coming-soon&percnt;2F&t&equals;A&plus;Look&plus;at&plus;Possible&plus;COVID-19&plus;Vaccines&plus;Coming&plus;Soon" title&equals;"Share on Share" onclick&equals;"essb&period;window&lpar;&&num;39&semi;https&colon;&sol;&sol;www&period;facebook&period;com&sol;sharer&sol;sharer&period;php&quest;u&equals;https&percnt;3A&percnt;2F&percnt;2Fwww&period;explosion&period;com&percnt;2F138042&percnt;2Fa-look-at-possible-covid-19-vaccines-coming-soon&percnt;2F&t&equals;A&plus;Look&plus;at&plus;Possible&plus;COVID-19&plus;Vaccines&plus;Coming&plus;Soon&&num;39&semi;&comma;&&num;39&semi;facebook&&num;39&semi;&comma;&&num;39&semi;2123751921&&num;39&semi;&rpar;&semi; return false&semi;" target&equals;"&lowbar;blank" rel&equals;"nofollow" class&equals;"nolightbox essb-s-bg-facebook essb-s-c-light essb-s-ch-light essb-s-bgh-dark essb-s-bg-network" ><span class&equals;"essb&lowbar;icon essb&lowbar;icon&lowbar;facebook"><svg class&equals;"essb-svg-icon essb-svg-icon-facebook" aria-hidden&equals;"true" role&equals;"img" focusable&equals;"false" xmlns&equals;"http&colon;&sol;&sol;www&period;w3&period;org&sol;2000&sol;svg" width&equals;"16" height&equals;"16" viewBox&equals;"0 0 16 16"><path d&equals;"M16 8&period;049c0-4&period;446-3&period;582-8&period;05-8-8&period;05C3&period;58 0-&period;002 3&period;603-&period;002 8&period;05c0 4&period;017 2&period;926 7&period;347 6&period;75 7&period;951v-5&period;625h-2&period;03V8&period;05H6&period;75V6&period;275c0-2&period;017 1&period;195-3&period;131 3&period;022-3&period;131&period;876 0 1&period;791&period;157 1&period;791&period;157v1&period;98h-1&period;009c-&period;993 0-1&period;303&period;621-1&period;303 1&period;258v1&period;51h2&period;218l-&period;354 2&period;326H9&period;25V16c3&period;824-&period;604 6&period;75-3&period;934 6&period;75-7&period;951"><&sol;path><&sol;svg><&sol;span><span class&equals;"essb&lowbar;network&lowbar;name">Share<&sol;span><&sol;a><&sol;li><li class&equals;"essb&lowbar;item essb&lowbar;link&lowbar;twitter nolightbox essb&lowbar;link&lowbar;twitter&lowbar;x essb&lowbar;link&lowbar;svg&lowbar;icon"> <a href&equals;"https&colon;&sol;&sol;x&period;com&sol;intent&sol;post&quest;text&equals;A&percnt;20Look&percnt;20at&percnt;20Possible&percnt;20COVID-19&percnt;20Vaccines&percnt;20Coming&percnt;20Soon&amp&semi;url&equals;https&percnt;3A&percnt;2F&percnt;2Fwww&period;explosion&period;com&percnt;2F138042&percnt;2Fa-look-at-possible-covid-19-vaccines-coming-soon&percnt;2F" title&equals;"Share on Tweet" onclick&equals;"essb&period;window&lpar;&&num;39&semi;https&colon;&sol;&sol;x&period;com&sol;intent&sol;post&quest;text&equals;A&percnt;20Look&percnt;20at&percnt;20Possible&percnt;20COVID-19&percnt;20Vaccines&percnt;20Coming&percnt;20Soon&amp&semi;url&equals;https&percnt;3A&percnt;2F&percnt;2Fwww&period;explosion&period;com&percnt;2F138042&percnt;2Fa-look-at-possible-covid-19-vaccines-coming-soon&percnt;2F&&num;39&semi;&comma;&&num;39&semi;twitter&&num;39&semi;&comma;&&num;39&semi;2123751921&&num;39&semi;&rpar;&semi; return false&semi;" target&equals;"&lowbar;blank" rel&equals;"nofollow" class&equals;"nolightbox essb-s-bg-twitter essb-s-c-light essb-s-ch-light essb-s-bgh-dark essb-s-bg-network" ><span class&equals;"essb&lowbar;icon essb&lowbar;icon&lowbar;twitter&lowbar;x"><svg class&equals;"essb-svg-icon essb-svg-icon-twitter&lowbar;x" aria-hidden&equals;"true" role&equals;"img" focusable&equals;"false" viewBox&equals;"0 0 24 24"><path d&equals;"M18&period;244 2&period;25h3&period;308l-7&period;227 8&period;26 8&period;502 11&period;24H16&period;17l-5&period;214-6&period;817L4&period;99 21&period;75H1&period;68l7&period;73-8&period;835L1&period;254 2&period;25H8&period;08l4&period;713 6&period;231zm-1&period;161 17&period;52h1&period;833L7&period;084 4&period;126H5&period;117z"><&sol;path><&sol;svg><&sol;span><span class&equals;"essb&lowbar;network&lowbar;name">Tweet<&sol;span><&sol;a><&sol;li><li class&equals;"essb&lowbar;item essb&lowbar;link&lowbar;pinterest nolightbox essb&lowbar;link&lowbar;svg&lowbar;icon"> <a href&equals;"&num;" title&equals;"Share on Pin It" onclick&equals;"essb&period;pinterest&lowbar;picker&lpar;&&num;39&semi;2123751921&&num;39&semi;&rpar;&semi; return false&semi;" target&equals;"&lowbar;blank" rel&equals;"nofollow" class&equals;"nolightbox essb-s-bg-pinterest essb-s-c-light essb-s-ch-light essb-s-bgh-dark essb-s-bg-network" ><span class&equals;"essb&lowbar;icon essb&lowbar;icon&lowbar;pinterest"><svg class&equals;"essb-svg-icon essb-svg-icon-pinterest" aria-hidden&equals;"true" role&equals;"img" focusable&equals;"false" width&equals;"32" height&equals;"32" viewBox&equals;"0 0 32 32" xmlns&equals;"http&colon;&sol;&sol;www&period;w3&period;org&sol;2000&sol;svg"><path d&equals;"M10&period;625 12&period;25c0-1&period;375 0&period;313-2&period;5 1&period;063-3&period;438 0&period;688-0&period;938 1&period;563-1&period;438 2&period;563-1&period;438 0&period;813 0 1&period;438 0&period;25 1&period;875 0&period;813s0&period;688 1&period;25 0&period;688 2&period;063c0 0&period;5-0&period;125 1&period;125-0&period;313 1&period;813-0&period;188 0&period;75-0&period;375 1&period;625-0&period;688 2&period;563-0&period;313 1-0&period;563 1&period;75-0&period;688 2&period;313-0&period;25 1-0&period;063 1&period;875 0&period;563 2&period;625 0&period;625 0&period;688 1&period;438 1&period;063 2&period;438 1&period;063 1&period;75 0 3&period;188-1 4&period;313-2&period;938 1&period;125-2 1&period;688-4&period;375 1&period;688-7&period;188 0-2&period;125-0&period;688-3&period;875-2&period;063-5&period;25-1&period;375-1&period;313-3&period;313-2-5&period;813-2-2&period;813 0-5&period;063 0&period;875-6&period;75 2&period;688-1&period;75 1&period;75-2&period;625 3&period;875-2&period;625 6&period;375 0 1&period;5 0&period;438 2&period;75 1&period;25 3&period;75 0&period;313 0&period;313 0&period;375 0&period;688 0&period;313 1&period;063-0&period;125 0&period;313-0&period;25 0&period;813-0&period;375 1&period;5-0&period;063 0&period;25-0&period;188 0&period;438-0&period;375 0&period;5s-0&period;375 0&period;063-0&period;563 0c-1&period;313-0&period;563-2&period;25-1&period;438-2&period;938-2&period;75s-1-2&period;813-1-4&period;5c0-1&period;125 0&period;188-2&period;188 0&period;563-3&period;313s0&period;875-2&period;188 1&period;625-3&period;188c0&period;75-1&period;063 1&period;688-1&period;938 2&period;688-2&period;75 1&period;063-0&period;813 2&period;313-1&period;438 3&period;875-1&period;938 1&period;5-0&period;438 3&period;125-0&period;688 4&period;813-0&period;688 1&period;813 0 3&period;438 0&period;313 4&period;938 0&period;938 1&period;5 0&period;563 2&period;813 1&period;375 3&period;813 2&period;375 1&period;063 1&period;063 1&period;813 2&period;188 2&period;438 3&period;5 0&period;563 1&period;313 0&period;875 2&period;688 0&period;875 4&period;063 0 3&period;75-0&period;938 6&period;875-2&period;875 9&period;313-1&period;938 2&period;5-4&period;375 3&period;688-7&period;375 3&period;688-1 0-1&period;938-0&period;188-2&period;813-0&period;688-0&period;875-0&period;438-1&period;5-1-1&period;875-1&period;688-0&period;688 2&period;938-1&period;125 4&period;688-1&period;313 5&period;25-0&period;375 1&period;438-1&period;25 3&period;188-2&period;688 5&period;25h-1&period;313c-0&period;25-2&period;563-0&period;188-4&period;688 0&period;188-6&period;375l2&period;438-10&period;313c-0&period;375-0&period;813-0&period;563-1&period;813-0&period;563-3&period;063z"><&sol;path><&sol;svg><&sol;span><span class&equals;"essb&lowbar;network&lowbar;name">Pin It<&sol;span><&sol;a><&sol;li><li class&equals;"essb&lowbar;item essb&lowbar;link&lowbar;mail nolightbox essb&lowbar;link&lowbar;svg&lowbar;icon"> <a href&equals;"&num;" title&equals;"Share on Email" onclick&equals;"essb&lowbar;open&lowbar;mailform&lpar;&&num;39&semi;2123751921&&num;39&semi;&rpar;&semi; return false&semi;" target&equals;"&lowbar;blank" rel&equals;"nofollow" class&equals;"nolightbox essb-s-bg-mail essb-s-c-light essb-s-ch-light essb-s-bgh-dark essb-s-bg-network" ><span class&equals;"essb&lowbar;icon essb&lowbar;icon&lowbar;mail"><svg class&equals;"essb-svg-icon essb-svg-icon-mail" aria-hidden&equals;"true" role&equals;"img" focusable&equals;"false" width&equals;"32" height&equals;"32" xmlns&equals;"http&colon;&sol;&sol;www&period;w3&period;org&sol;2000&sol;svg" viewBox&equals;"0 0 60 60"><polygon points&equals;"60&comma;50&period;234 60&comma;9&period;944 39&period;482&comma;30&period;536 " &sol;><polygon points&equals;"0&comma;9&period;941 0&comma;50&period;234 20&period;519&comma;30&period;535 " &sol;><path d&equals;"M1&period;387&comma;8&period;5l21&period;002&comma;21&period;08c0&period;121&comma;0&period;051&comma;0&period;471&comma;0&period;415&comma;0&period;517&comma;0&period;519l5&period;941&comma;5&period;963c0&period;635&comma;0&period;591&comma;1&period;672&comma;0&period;59&comma;2&period;333-0&period;025l5&period;911-5&period;933c0&period;046-0&period;105&comma;0&period;4-0&period;473&comma;0&period;522-0&period;524L58&period;615&comma;8&period;5H1&period;387z" &sol;><path d&equals;"M38&period;07&comma;31&period;954l-5&period;5&comma;5&period;52c-0&period;73&comma;0&period;68-1&period;657&comma;1&period;019-2&period;58&comma;1&period;019c-0&period;914&comma;0-1&period;823-0&period;332-2&period;533-0&period;993l-5&period;526-5&period;546L1&period;569&comma;51&period;5h56&period;862L38&period;07&comma;31&period;954z" &sol;><&sol;svg><&sol;span><span class&equals;"essb&lowbar;network&lowbar;name">Email<&sol;span><&sol;a><&sol;li><&sol;ul><&sol;div>


0 Comments

Your email address will not be published. Required fields are marked *

Exit mobile version
Send this to a friend